PackagesCanonicalsLogsProblems
    Packages
    de.medizininformatikinitiative.kerndatensatz.mtb@2025.0.0-ballot
    https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1
{
  "description": "Immunhistorchemistry report",
  "_filename": "StructureDefinition-mii-pr-mtb-immunohistochemistry-pdl1.json",
  "package_name": "de.medizininformatikinitiative.kerndatensatz.mtb",
  "date": null,
  "derivation": "constraint",
  "publisher": "Medizininformatik Initiative",
  "fhirVersion": "4.0.1",
  "name": "MII_PR_MTB_Immunohistochemistry_PDL1",
  "abstract": false,
  "type": "Observation",
  "experimental": null,
  "resourceType": "StructureDefinition",
  "title": "MII PR MTB Immunohistochemistry",
  "package_version": "2025.0.0-ballot",
  "status": "draft",
  "id": "d00b8929-f8f7-4392-aa7a-18faf1069fa2",
  "kind": "resource",
  "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry-pdl1",
  "version": "2024.0.0-ballot",
  "differential": {
    "element": [ {
      "id": "Observation.effective[x]",
      "path": "Observation.effective[x]",
      "type": [ {
        "code": "dateTime"
      } ],
      "mustSupport": true
    }, {
      "id": "Observation.specimen",
      "path": "Observation.specimen",
      "short": "Probe",
      "definition": "Probe"
    }, {
      "id": "Observation.component",
      "path": "Observation.component",
      "slicing": {
        "rules": "open",
        "ordered": false,
        "description": "Immunohistochemische Ergebnisse",
        "discriminator": [ {
          "path": "code",
          "type": "value"
        } ]
      }
    }, {
      "id": "Observation.component:tps-score",
      "max": "1",
      "min": 0,
      "path": "Observation.component",
      "short": "TPS-Score",
      "sliceName": "tps-score",
      "definition": "Tumor Proportion Score (TPS) - Score für PD-L1-Expression in Tumorzellen. Der TPS ist der Anteil der PD-L1-positiven Tumorzellen im Verhältnis zu den Gesamtzellen. Der TPS wird in Prozent angegeben. Ein TPS von 1% oder mehr gilt als positiv.",
      "mustSupport": true
    }, {
      "id": "Observation.component:tps-score.code",
      "path": "Observation.component.code",
      "mustSupport": true,
      "patternCodeableConcept": {
        "coding": [ {
          "code": "C184941",
          "system": "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
          "display": "PD-L1 Tumor Proportion Score"
        } ]
      }
    }, {
      "id": "Observation.component:tps-score.value[x]",
      "path": "Observation.component.value[x]",
      "slicing": {
        "rules": "open",
        "ordered": false,
        "discriminator": [ {
          "path": "$this",
          "type": "type"
        } ]
      }
    }, {
      "id": "Observation.component:tps-score.value[x]:valueQuantity",
      "max": "1",
      "min": 0,
      "path": "Observation.component.value[x]",
      "type": [ {
        "code": "Quantity"
      } ],
      "sliceName": "valueQuantity",
      "mustSupport": true
    }, {
      "id": "Observation.component:tps-score.interpretation",
      "path": "Observation.component.interpretation",
      "mustSupport": true
    }, {
      "id": "Observation.component:cps-score",
      "max": "1",
      "min": 0,
      "path": "Observation.component",
      "short": "CPS-Score",
      "sliceName": "cps-score",
      "definition": "Combined Positive Score (CPS) - Score für PD-L1-Expression in Tumorzellen und Immunzellen. Der CPS ist der Anteil der PD-L1-positiven Tumorzellen und Immunzellen im Verhältnis zu den Gesamtzellen. Der CPS wird in Prozent angegeben. Ein CPS von 1% oder mehr gilt als positiv.",
      "mustSupport": true
    }, {
      "id": "Observation.component:cps-score.code",
      "path": "Observation.component.code",
      "mustSupport": true,
      "patternCodeableConcept": {
        "coding": [ {
          "code": "C176582",
          "system": "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
          "display": "PD-L1 Combined Positive Score"
        } ]
      }
    }, {
      "id": "Observation.component:cps-score.value[x]",
      "path": "Observation.component.value[x]",
      "slicing": {
        "rules": "open",
        "ordered": false,
        "discriminator": [ {
          "path": "$this",
          "type": "type"
        } ]
      }
    }, {
      "id": "Observation.component:cps-score.value[x]:valueQuantity",
      "max": "1",
      "min": 0,
      "path": "Observation.component.value[x]",
      "type": [ {
        "code": "Quantity"
      } ],
      "sliceName": "valueQuantity",
      "mustSupport": true
    }, {
      "id": "Observation.component:cps-score.interpretation",
      "path": "Observation.component.interpretation",
      "mustSupport": true
    }, {
      "id": "Observation.component:ics-score",
      "max": "1",
      "min": 0,
      "path": "Observation.component",
      "short": "ICS-Score",
      "sliceName": "ics-score",
      "definition": "Immune Cell Score (ICS) - Score für PD-L1-Expression in Immunzellen. Der ICS ist der Anteil der PD-L1-positiven Immunzellen im Verhältnis zu den Gesamtzellen. Der ICS wird in Prozent angegeben. Ein ICS von 1% oder mehr gilt als positiv.",
      "mustSupport": true
    }, {
      "id": "Observation.component:ics-score.code",
      "path": "Observation.component.code",
      "mustSupport": true,
      "patternCodeableConcept": {
        "coding": [ {
          "code": "C199175",
          "system": "https://nih-ncpi.github.io/ncpi-fhir-ig/CodeSystem-ncit.html",
          "display": "Cells.programmed cell death ligand 1/Viable tumor cells in Tissue by Immune stain"
        } ]
      }
    }, {
      "id": "Observation.component:ics-score.value[x]",
      "path": "Observation.component.value[x]",
      "slicing": {
        "rules": "open",
        "ordered": false,
        "discriminator": [ {
          "path": "$this",
          "type": "type"
        } ]
      }
    }, {
      "id": "Observation.component:ics-score.value[x]:valueQuantity",
      "max": "1",
      "min": 0,
      "path": "Observation.component.value[x]",
      "type": [ {
        "code": "Quantity"
      } ],
      "sliceName": "valueQuantity",
      "mustSupport": true
    }, {
      "id": "Observation.component:ics-score.interpretation",
      "path": "Observation.component.interpretation",
      "mustSupport": true
    }, {
      "id": "Observation.component:tc-score",
      "max": "1",
      "min": 0,
      "path": "Observation.component",
      "short": "TC-Score / TPS-Score",
      "sliceName": "tc-score",
      "definition": "Tumor Cell Score (TC-Score) - Score für PD-L1-Expression in Tumorzellen. Der TC-Score ist der Anteil der PD-L1-positiven Tumorzellen im Verhältnis zu den Gesamtzellen. Der TC-Score wird in Prozent angegeben. Ein TC-Score von 1% oder mehr gilt als positiv.",
      "mustSupport": true
    }, {
      "id": "Observation.component:tc-score.code",
      "path": "Observation.component.code",
      "mustSupport": true,
      "patternCodeableConcept": {
        "coding": [ {
          "code": "83053-9",
          "system": "http://loinc.org",
          "display": "Cells.programmed cell death ligand 1/Viable tumor cells in Tissue by Immune stain"
        } ]
      }
    }, {
      "id": "Observation.component:tc-score.value[x]",
      "path": "Observation.component.value[x]",
      "slicing": {
        "rules": "open",
        "ordered": false,
        "discriminator": [ {
          "path": "$this",
          "type": "type"
        } ]
      }
    }, {
      "id": "Observation.component:tc-score.value[x]:valueQuantity",
      "max": "1",
      "min": 0,
      "path": "Observation.component.value[x]",
      "type": [ {
        "code": "Quantity"
      } ],
      "sliceName": "valueQuantity",
      "mustSupport": true
    }, {
      "id": "Observation.component:tc-score.interpretation",
      "path": "Observation.component.interpretation",
      "mustSupport": true
    } ]
  },
  "contact": [ {
    "telecom": [ {
      "value": "https://www.medizininformatik-initiative.de",
      "system": "url"
    } ]
  } ],
  "baseDefinition": "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-immunohistochemistry"
}